Henry Ford Health System

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).

234 total trials 43 currently recruiting 148 completed top decile by trial count

Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.

Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.

Top-decile sponsor footprint

Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

234 total, page 3 of 5

COMPLETED NA

Pleth Variability Index (PVI) as a Measure of Volume Status During Transcatheter Mitral Valve Repair

NCT03993938

TERMINATED NA

Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure

NCT04095416

COMPLETED Early Phase 1

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

NCT03858543

COMPLETED Phase 2

The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

NCT03887377

TERMINATED

Mesothelioma Early Detection by VOCs

NCT04106973

COMPLETED NA

The Improving ATTENDance to Cardiac Rehabilitation Trial

NCT03646760

COMPLETED

Preoperative Hip Knee Anxiety Sleep Study

NCT04180527

COMPLETED Phase 2

Nonopioid Analgesia After Rotator Cuff Repair

NCT03818919

COMPLETED Phase 2

Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

NCT03818932

COMPLETED Early Phase 1

Nonopioid Analgesia After Arthroscopic Meniscus Surgery

NCT03820193

COMPLETED NA

TEE Image Quality Improvement With Our Devised Probe Cover

NCT03812185

COMPLETED NA

Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma

NCT03958006

COMPLETED NA

B/F/TAF Ease of Swallowability Trial

NCT04600687

COMPLETED Phase 4

The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown

NCT03929224

COMPLETED NA

Subscapularis Strength After Total Shoulder Arthroplasty

NCT03854357

COMPLETED NA

A Brief Intervention for Chronic Pain in Primary Care

NCT03692468

COMPLETED NA

Insomnia and Rumination in Late Pregnancy and the Risk for Postpartum Depression

NCT03596879

COMPLETED Early Phase 1

The Fruit and Vegetable Prescription Program Study

NCT04597957

COMPLETED Phase 4

Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs

NCT03312517

COMPLETED Phase 2

Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant

NCT03850379

COMPLETED NA

The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects

NCT03065582

COMPLETED NA

Sleep To Reduce Incident Depression Effectively

NCT03322774

TERMINATED NA

Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo

NCT05238077

COMPLETED

Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function

NCT03814031

TERMINATED NA

Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis Suppurativa

NCT05830149

COMPLETED NA

Remote Ischemic Preconditioning for Renal Protection in TAVI

NCT03347032

COMPLETED Phase 2

Topical Capsaicin for Cyclical Vomiting

NCT03223350

COMPLETED NA

Effect of Emergency Department Bedside Compression Ultrasonography on Door-to-Disposition Time in Patients Suspicious for Lower Extremity Deep Venous Thrombosis

NCT05682040

TERMINATED NA

Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients

NCT03180398

TERMINATED NA

Adaptive Cardiac Resynchronization Therapy in Patients With RBBB

NCT05936294

COMPLETED NA

A Brief Intervention for Patients on Opioids for Acute Pain

NCT05658926

COMPLETED Phase 4

Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty

NCT03375112

COMPLETED NA

Effects of Preoperative Carbohydrate Rich Drinks on Immediate Postoperative Outcome in Total Knee Arthroplasty

NCT03380754

COMPLETED Phase 1

Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer

NCT03281382

COMPLETED Phase 3

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

NCT03269344

COMPLETED NA

Achilles Tendon Lengthening With Traditional vs. Accelerated Rehab

NCT04050748

COMPLETED NA

Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes

NCT02850224

COMPLETED Phase 4

Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy

NCT03250507

COMPLETED Phase 4

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

NCT03037515

COMPLETED NA

Does Transesophageal Echocardiography Along With an Orogastric Tube Improve the Image Quality Intraoperatively?

NCT03454399

COMPLETED Phase 4

Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

NCT02980926

COMPLETED

Emergency Department, Rapid Assessment for Sexually Transmitted Infection

NCT02386514

COMPLETED NA

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

NCT02796365

COMPLETED

National Cardiogenic Shock Initiative

NCT03677180

COMPLETED NA

Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength

NCT03033589

COMPLETED Early Phase 1

Pain Control After Total Knee Arthroplasty: Benefit In Adding Single Shot Adductor Canal Block to Existing Pain Regimen Protocol?

NCT02740192

COMPLETED NA

Sleep to Prevent Evolving Affecting Disorders

NCT02988375

TERMINATED NA

Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction

NCT02762825

COMPLETED NA

The Efficacy of Bakuchiol in Treating PIH

NCT06833996

COMPLETED NA

An In Vivo Model for Postinflammatory Hyperpigmentation

NCT02905903

← Previous Page 3 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 15
Phase 2 23
Phase 3 9
Phase 4 26

What is open in the Henry Ford Health System pipeline

43 recruiting of 234 indexed (18% open); 148 completed (63%).

Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).

Top condition: Insomnia (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Henry Ford Health System: open-pipeline peers nationwide

Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 10%12%14%16%18%20% Total trials Recruiting share Henry Ford Health SystemDaiichi SankyoLoma Linda UniversityBrown UniversityUniversity Hospitals Cleveland Medical CenterNew York Institute of TechnologyUniversity of Maryland, BaltimoreAbramson Cancer Center at Penn MedicineUniversity of California, San Diego
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 234 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this Henry Ford Health System page

234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.

  • 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.